{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16640", "batch_size": 260, "batch_pos": 162, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment neutrally states uncertainty and attribution ('too early to tell how many doses', 'said').", "method": "llm_batch", "batch_id": "batch_2_9260", "batch_size": 260, "batch_pos": 158, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "Hypothetical outcome, not realised impact.", "method": "llm_batch", "batch_id": "batch_3_17104", "batch_size": 260, "batch_pos": 132, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_15972", "batch_size": 260, "batch_pos": 128, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "This segment states it is too early to tell manufacturing numbers but provides no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_4508", "batch_size": 260, "batch_pos": 127, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15536", "batch_size": 260, "batch_pos": 120, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment contains 'too early to tell', but this is not a bare negation about a risk, threat, or fact in the Q7 sense.", "method": "llm_batch", "batch_id": "batch_7_14876", "batch_size": 260, "batch_pos": 113, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes uncertainty about a manufacturing capability ('how many doses Moderna will be able to manufacture') without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_14816", "batch_size": 260, "batch_pos": 83, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
